United States · Wires & real time · Business Wire

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Published by Business Wire · United States 13 h ago

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced plans to enhance its ...

Read the full article on Business Wire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)

Also worth reading

PR Newswire

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Associated Press (Business)

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Dow Jones Newswires

GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis

Share

Also worth reading

LAZ and indiGOtech Form Joint Venture to Bring Sustainable EV Charging to More Apartments and Condos

Houthi strikes on Saudi Arabia show the Yemeni rebels’ growing strength

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening